Assessment of Medication Adherence in Ccu Admitted Patients

This study aims to assess medication adherence and the appropriateness of prescribed medications among patients admitted to the Coronary Care Unit (CCU). The study will use the Medication Appropriateness Index (MAI) to evaluate the suitability of prescribed medications and the Beliefs about Medicines Questionnaire (BMQ) to assess patients' beliefs and perceptions regarding their medications. Understanding medication adherence and related beliefs may help identify factors associated with inappropriate medication use and non-adherence in hospitalized cardiac patients. The findings of this study may contribute to improving medication management and patient care in the CCU setting.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Heart Failure Arrhythmias, Cardiac Atrial Fibrillation Atrial Fibrillation (AF) Behavior Cardiovascular Diseases Health Behavior Heart Diseases Medication Adherence Pathologic Processes Pathological Conditions, Signs and Symptoms Patient Acceptance of Health Care Patient Compliance Treatment Adherence and Compliance

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Al-Nasiriyah Heart Center, Nasiriyah, Thi Qar, Iraq

About this study

This is a cross-sectional observational study conducted in the Coronary Care Unit (CCU). The study evaluates medication adherence and the appropriateness of prescribed medications among hospitalized cardiac patients. Medication appropriateness is assessed using the Medication Appropriateness Index (MAI), and patients' beliefs about medicines are assessed using the Beliefs about Medicines Questionnaire (BMQ). Data are collected through medical record review and patient interviews during hospitalization. The study involves no intervention or modification of routine clinical care.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult patients aged 18 years or older
Diagnosed with atrial fibrillation or heart failure
Admitted to the coronary care unit
Clinically stable at the time of interview
Able to provide informed consent

Exclusion criteria

Significant cognitive impairment
Communication difficulties preventing interview
Diagnosed psychiatric disorder interfering with participation

Treatment and study plan

No intervention (observational study)

Other

This is an observational study with no active intervention.

Primary outcomes

Medication adherence (BMQ)

Time frame: During CCU admission after clinical stabilization (assessed up to 5 days)

Medication adherence will be assessed using the Brief Medication Questionnaire (BMQ), a validated tool that evaluates medication-taking behavior and barriers to adherence.
Medication appropriateness measured by Medication Appropriateness Index (MAI)

Time frame: During CCU admission after clinical stabilization (assessed up to 5 days)

Medication appropriateness will be assessed using the Medication Appropriateness Index (MAI). The MAI score ranges from 0 to 12, where lower scores indicate better medication adherence and higher scores indicate poorer adherence.

Study contacts

Contact information is provided by the study sponsor or research team.

Suror S Alsabbagh, Bachelor of Pharmacy

CONTACT

[email protected]

+9647817091467

Sponsors and collaborators

Lead sponsor

AlFayhaa General Hospital

Other

Registry information

Important dates

Study start: 2026
Primary completion: 2026
Study completion: 2026
First posted: Mar 31, 2026
Registry last updated: Mar 31, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting